• Data
  • Studio
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Governance
    • Events
    • Newsroom
    • Careers
Contact us

Sign in

  • Data
  • Studio
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Governance
    • Events
    • Newsroom
    • Careers
Advancing epilepsy research: Insights from Truveta’s epilepsy data

Advancing epilepsy research: Insights from Truveta’s epilepsy data

by Truveta Staff | Sep 22, 2023 | Technology

Epilepsy is a complex neurological disorder, characterized by recurrent, unpredictable seizures. The fourth most common neurological disorder in the world, an estimated 3.4 million (3M adults and 470,000 children) have active epilepsy in the US. These seizures...
A journey into rare disease research

A journey into rare disease research

by Lisa Gurry, Chief Growth Officer | Jul 31, 2023 | Technology

Rare diseases as a category aren’t that rare if you consider they impact 30 million Americans and 400 million people around the world. Not to mention their families, who often become caregivers. Yet, with nearly 7,000 rare diseases (identified as of today…), each is...

Recent posts

  • De-risking clinical programs using data from EHRs: an example from medtech
  • Truveta recognized on LinkedIn Top Startups 2023 list
  • Advice from physicians as COVID and RSV cases begin to rise this fall


Stay up-to-date

Ready to join us on our mission of Saving Lives with Data?

Get started
  • Follow
  • Follow

Truveta Data

Truveta Studio

Research

Resources

Blog

Leadership

Governance

Newsroom

Careers

Contact us

Privacy Notice

© Truveta 2023

Interested in learning more?

Reach out and we’ll schedule a demo.